Our findings provide new insights into NARS2-related mitochondrial disease, highlighting the importance of comprehensive genetic testing, early recognition of acute manifestations, and multidisciplinary management to improve outcomes in affected individuals. The gene discussed is NARS2; the disease is mitochondrial disease.